Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be…
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Celecoxib.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Celecoxib shows recurring relationship patterns in the source. For example, Celecoxib → April, Brigham Young University, BYU, Cir, Co, COX-2, Daniel, Fed, It, John Talley, Monsanto, Monsanto's, Other, Pfizer, Rochester, Searle, Simmons, The, Two, University Another extracted example is Celecoxib → Anemia, Cardiovascular, Gastrointestinal, GI, Hematologic, Individual, Long-term, Moderate, New-onset, NSAIDs, People, Risk, The, These, Use, When. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
cox-2 risk pfizer drug may use nsaids effects celebrex people searle pain drugs cardiovascular used fda inhibition treatment anti-inflammatory cancer
TTTA extracted 168 structured relationships around Celecoxib. Examples in this analysis include Celecoxib → 3D model (JSmol) → Interactive image and Celecoxib → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Celecoxib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Celecoxib | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Celecoxib | ATC code | L01XX33 (WHO) M01AH01 (WHO) | 1.00 | infobox |
| Celecoxib | Bioavailability | Unknown | 1.00 | infobox |
| Celecoxib | CAS Number | 169590-42-5 Y | 1.00 | infobox |
| Celecoxib | ChEBI | CHEBI:41423 Y | 1.00 | infobox |
| Celecoxib | ChEMBL | ChEMBL118 Y | 1.00 | infobox |
| Celecoxib | ChemSpider | 2562 Y | 1.00 | infobox |
| Celecoxib | CompTox Dashboard (EPA) | DTXSID0022777 | 1.00 | infobox |
| Celecoxib | Drug class | Cyclooxygenase-2 (COX-2) inhibitor | 1.00 | infobox |
| Celecoxib | DrugBank | DB00482 Y | 1.00 | infobox |
| Celecoxib | ECHA InfoCard | 100.211.644 | 1.00 | infobox |
| Celecoxib | Elimination half-life | 7.8 hours; 11 hours (mild hepatic impairment); 13 hours (moderate-severe hepatic impairment) | 1.00 | infobox |
| Celecoxib | Excretion | Faeces (57%), urine (27%) | 1.00 | infobox |
| Celecoxib | Formula | C17H14F3N3O2S | 1.00 | infobox |
| Celecoxib | IUPHAR/BPS | 2892 | 1.00 | infobox |
| Celecoxib | KEGG | D00567 Y | 1.00 | infobox |
| Celecoxib | Legal status | AU: S4 (Prescription only) or S3 | 1.00 | infobox |
| Celecoxib | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Celecoxib | Legal status | CA: ℞-only | 1.00 | infobox |
| Celecoxib | Legal status | NZ: Prescription only | 1.00 | infobox |
| Celecoxib | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Celecoxib | Legal status | US: ℞-only | 1.00 | infobox |
| Celecoxib | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Celecoxib | License data | US DailyMed: Celecoxib | 1.00 | infobox |
| Celecoxib | MedlinePlus | a699022 | 1.00 | infobox |
| Celecoxib | Metabolism | Liver (mainly CYP2C9) | 1.00 | infobox |
| Celecoxib | Molar mass | 381.37 g·mol−1 | 1.00 | infobox |
| Celecoxib | PDB ligand | CEL (PDBe, RCSB PDB) | 1.00 | infobox |
| Celecoxib | Pregnancy category | AU: B3 | 1.00 | infobox |
The concept neighborhoods around Celecoxib bring nearby vocabulary together. In this analysis, examples include Cox-2, Selective and Inhibition. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Celecoxib, one of the stronger structural bridges in this analysis connects Celecoxib with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Celecoxib to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Celecoxib · EN edition · Analysis: TopicsToTalkAbout